ImmuCell
ICCC
28 hedge funds and large institutions have $5.31M invested in ImmuCell in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 4 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
0.1% more ownership
Funds ownership: 13.35% → 13.45% (+0.1%)
3% less capital invested
Capital invested by funds: $5.47M → $5.31M (-$162K)
7% less funds holding
Funds holding: 30 → 28 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$96.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$78.9K |
| 3 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$59.4K |
| 4 |
Renaissance Technologies
New York
|
+$23.5K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$144K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$77.5K |
| 3 |
HL
HeadInvest LLC
Portland,
Maine
|
-$16.3K |
| 4 |
Morgan Stanley
New York
|
-$16.1K |
| 5 |
BlackRock
New York
|
-$4.48K |
ICCC Hedge Fund Activity: Q4 2023 in Review
28 of the 6,870 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2023, worth a combined $5.31M — down 3% from $5.47M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ICCC and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 9 added.
The largest buyer was Northern Trust, adding an estimated $96.5K. The largest seller was Perritt Capital Management, exiting entirely with an estimated $144K sold.
- 28 institutional investors held ImmuCell (ICCC) as of Q4 2023, down from 30 in Q3 2023.
- Funds reported $5.31M of ImmuCell stock for Q4 2023, down 3% quarter-over-quarter.
- 2 funds opened new ImmuCell positions in Q4 2023 and 4 closed out, a net change of -2 holders.
- The largest ImmuCell buyer in Q4 2023 was Northern Trust, an estimated $96.5K added.
- The largest ImmuCell seller in Q4 2023 was Perritt Capital Management, an estimated $144K sold.
Based on aggregated 13F filings for Q4 2023.